Cargando…
Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357256/ https://www.ncbi.nlm.nih.gov/pubmed/32661911 http://dx.doi.org/10.1007/s40261-020-00948-w |